MICROVISION INC (MVIS)
Sector: Information Technology
2026 Annual Meeting Analysis
MICROVISION INC · Meeting: July 10, 2026
Directors FOR
4
Directors AGAINST
3
Say on Pay
AGAINST
Auditor
FOR
Director Elections
Election of Directors
Against Analysis
Mr. Biddiscombe has served since 2018 and the stock has declined approximately 95% over three years and 98% over five years, deeply exceeding the 30-percentage-point underperformance threshold that applies under the ETF fallback benchmark (XLK) for companies with negative absolute three-year returns; the five-year record does not provide a mitigant because underperformance is sustained across both periods.
Mr. Carlile has served as a director since 2017 and as Board Chair since 2022; with MVIS down approximately 95% over three years and 98% over five years against the XLK benchmark, the underperformance far exceeds the applicable 30-percentage-point threshold, and the five-year record provides no mitigant given the sustained nature of the decline.
Mr. Herbst has served since 2022 and his tenure covers well over 24 months of the three-year underperformance window; the stock's approximately 95% three-year decline far exceeds the 30-percentage-point ETF fallback threshold applicable to companies with negative absolute returns, and the five-year record is similarly deeply negative with no mitigant.
For Analysis
Mr. DeVos joined the board in 2025 and is exempt from the TSR underperformance trigger under the policy's 24-month new director exemption; as the newly appointed CEO he has not had a reasonable opportunity to influence the board's long-term performance record.
Ms. Peterson joined the board in July 2025, well within the 24-month new director exemption, so the TSR underperformance trigger does not apply to her; she has not had a reasonable opportunity to contribute to a turnaround.
Mr. Schabert joined in 2024 and has served for less than two years, meaning his tenure covers less than half of the three-year underperformance period; under the policy this is flagged but does not automatically result in a AGAINST vote, and the policy gives newer directors time to contribute before being held accountable for prior-period performance.
Ms. Smith joined in 2024 and has served for less than two years, covering less than half of the three-year underperformance window; consistent with policy, this is flagged as context but does not automatically trigger a AGAINST vote given her limited tenure.
The board presents seven nominees. Three long-tenured directors (Biddiscombe since 2018, Carlile since 2017, Herbst since 2022) receive AGAINST votes because MVIS's approximately 95% three-year price decline and approximately 98% five-year decline far exceed the ETF fallback underperformance threshold (XLK; 30 percentage points for companies with negative absolute three-year returns), and the five-year record provides no mitigant. Two very new directors (DeVos and Peterson, both 2025) are exempt under the 24-month new director rule. Two directors added in 2024 (Schabert and Smith) are flagged but receive FOR votes because their tenure covers less than half the underperformance period.
Say on Pay
✗ AGAINSTCEO
Glen DeVos
Total Comp
$3,387,845
Prior Support
N/A
While CEO Glen DeVos only joined in late 2025 and his $3.39 million total compensation package is largely composed of equity (approximately 90% in stock awards), the primary equity grant of 1,300,000 RSUs awarded as an inducement vests purely on a time/service schedule over four years with no performance conditions attached — meaning the largest single component of pay is effectively fixed compensation disguised as variable pay regardless of shareholder outcomes. The company lost approximately $95 million in 2025, the stock declined approximately 95% over three years, and the short-term bonus plan's performance hurdles (at least $10 million in revenue, no more than $55 million in cash operating expenses) are modest relative to the company's scale of losses and do not include any long-term stock price or return targets that would meaningfully tie executive outcomes to the shareholder experience. This combination of a large time-vesting-only equity grant alongside a pattern of deep value destruction represents a pay-for-performance failure that warrants a AGAINST vote.
Auditor Ratification
✓ FORAuditor
Baker Tilly US, LLP
Tenure
N/A
Audit Fees
$673,020
Non-Audit Fees
$122,585
Non-audit fees (audit-related fees of $82,700 plus tax fees of $39,885, totaling approximately $122,585) represent about 18% of audit fees of $673,020, well below the 50% threshold that would raise independence concerns; auditor tenure is not explicitly disclosed so the tenure trigger cannot fire; and Baker Tilly is a large national firm appropriate for a sub-$1B company.
Overall Assessment
The 2026 MicroVision annual meeting presents five proposals across a company in significant financial distress, with the stock down approximately 95% over three years and facing Nasdaq delisting risk. The most consequential governance concerns are the three long-tenured directors who oversaw the period of deep value destruction (AGAINST votes for Biddiscombe, Carlile, and Herbst) and an executive compensation program where the CEO's largest equity award vests purely on time with no performance conditions, creating a pay-for-performance disconnect despite the company's severe losses.